Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Leukemia its origin, types, risk factors and survivorship

Breadcrumb

  • Home
  • Leukemia its origin, types, risk factors and survivorship

Gayatri Jaiswal 1, Rajani Dubey 2 and Krishna Kumar Prajapati 2, *

1 Department of Zoology, Swami Devanand Post Graduate College Mathlar Deoria, U.P, India.
2 Department of Zoology, Marwar Business School, Naseerabad Gorakhpur, U.P., India.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 283–292.
Article DOI: 10.30574/wjbphs.2024.18.1.0083
DOI url: https://doi.org/10.30574/wjbphs.2024.18.1.0083

Received on 02 March 2024; revised on 10 April 2024; accepted on 12 April 2024

Leukemia cancer; Feline leukemia virus (FeLV); CAR-Natural Killer and CAR-macrophages; TPMT and NUDT15 genes; Thiopurines.Leukemia is a cancer of the body’s blood forming tissues such as bone marrow and the lymphatic system. It is most common cancer in the children but mostly occur in adults.The general symptoms in leukemia cancer are appetite and headaches, and red patches on the skin of patients.The hematopoietic stem cell help to regenerate the healthy and leukemia free cells of white blood cells in bone marrow of patients and slowly-slowly cure the leukemia patients. Feline leukemia virus (FeLV) is retrovirus globally impact on the health and cause tumor and bone marrow disorder and immune suppression. The CAR-Natural Killer and CAR-macrophages were introduced as a complement or alternative to CAR-T cells therapy for solid tumor. The thiopurines interfere with the synthesis of nucleic acids in leukemia affected cells in the bone marrow  and acting mainly in the S-phase of cell division process in cancerous cells and alloHSCT therapy use to combined targeted therapy and cure to certain types of acute myeloid leukemia which is create by TP53 mutations.The TPMT and NUDT15 genes evaluated their association with 6MP dose intensity and identified 5 and 6 coding variant in TPMT and NUDT15 respectively.

Leukemia cancer; Feline leukemia virus (FeLV); CAR-Natural Killer and CAR-macrophages; TPMT and NUDT15 genes; Thiopurines

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0083.pdf

Preview Article PDF

Gayatri Jaiswal, Rajani Dubey and Krishna Kumar Prajapati. Leukemia its origin, types, risk factors and survivorship. World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 283–292. Article DOI: https://doi.org/10.30574/wjbphs.2024.18.1.0083

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution